Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
459
-
Total 13F shares, excl. options
-
19M
-
Shares change
-
-315K
-
Total reported value, excl. options
-
$8.01B
-
Value change
-
-$128M
-
Put/Call ratio
-
1.44
-
Number of buys
-
245
-
Number of sells
-
-187
-
Price
-
$420.49
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q4 2022
534 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q4 2022.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 459 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (2.39M shares), BlackRock Inc. (1.58M shares), Veritas Asset Management LLP (1.15M shares), STATE STREET CORP (948K shares), BROWN ADVISORY INC (821K shares), ALLIANCEBERNSTEIN L.P. (481K shares), GEODE CAPITAL MANAGEMENT, LLC (435K shares), UBS ASSET MANAGEMENT AMERICAS INC (419K shares), BANK OF AMERICA CORP /DE/ (409K shares), and WESTFIELD CAPITAL MANAGEMENT CO LP (390K shares).
This table shows the top 459 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.